Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peter Sorger
Oregon Health & Science University, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
RareCyte, Inc.
Payment for services (e.g., consulting fees, honoraria, paid authorship)
RareCyte is a life science company focused on the development, commercialization and sale of technologies for imaging rare cells in human samples including blood and tissue. This multi-investigator HTAN project based at OHSU will construct a Human Tumor Atlas Network of breast and ovarian cancer; the Sorger lab will provide tissue-imaging technologies. RareCyte technologies will be used to conduct the research.
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
PROJECT NARRATIVE Treatments of metastatic breast and prostate cancers typically are not durable. The OMS Atlas project will apply state of the art analysis tools to tumor samples taken at multiple times during treatment in order to identify changes in the components and structures of these cancers that enable them to escape therapeutic control. This information will guide the development of new therapeutic approaches that can be used to reestablish control and develop new diagnostic procedures that will guide the use of these treatments.
Filed on November 16, 2018.
Tell us what you know about Peter Sorger's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Peter Sorger”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Peter Sorger | Harvard Medical School | Conflict of Interest | RareCyte | Value cannot be readily determined |
| Peter Sorger | Harvard Medical School | Conflict of Interest | RareCyte, Inc. | Value cannot be readily determined |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $0 - $4,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $10,000 - $19,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $10,000 - $19,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | RareCyte, Inc. | $10,000 - $19,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $200,000 - $249,999 |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Glencoe Software | $0 - $4,999 |
| Peter Sorger | Oregon Health & Science University | Conflict of Interest | RareCyte, Inc. | Value cannot be readily determined |
| Peter Sorger | Harvard Medical School | Conflict of Interest | Merrimack Pharmaceuticals, Inc. | $200,000 - $249,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.